NeuroBo Pharmaceuticals, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • NeuroBo Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -189 %, a 256% decline year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2023 was -59.4 %, a 48.5% increase from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2022 was -115 %, a 18.2% increase from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Return On Equity for 2021 was -141 %, a 56.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -59.4 +55.9 +48.5% Jan 1, 2023 Dec 31, 2023
2022 -115 +25.7 +18.2% Jan 1, 2022 Dec 31, 2022
2021 -141 +182 +56.3% Jan 1, 2021 Dec 31, 2021
2020 -323 -526 -259% Jan 1, 2020 Dec 31, 2020
2019 203 +389 Jan 1, 2019 Dec 31, 2019
2018 -186 +66.4 +26.3% Jan 1, 2018 Dec 31, 2018
2017 -252 +87.9 +25.8% Jan 1, 2017 Dec 31, 2017
2016 -340 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.